BCL2L1 and medical procedure: These findings indicate that BCL-xL expression and activity limit the chemosensitivity of patient-derived breast tumoroids. Finally, we observed that the most sensitive tumors (#2 and #5) were rendered more resistant to chemotherapy when treated in the presence of CAFs-conditioned media (Fig. 4G).